Why is Tecan stock surging today?

Tecan stock surged 9.6% today after the Swiss laboratory instruments maker published a third-quarter trading update revealing a clear acceleration in sales growth and lifted its full-year 2026 targets across both revenue and profitability metrics.

Third-quarter sales expanded 6.9% in local currencies, a notable pick-up from the pace recorded in the first half of the year, while order entry rose 3.1% in local currencies despite lapping a demanding comparison period from the prior year.

On the guidance front, management raised its full-year 2026 sales growth forecast from low single digits to low-to-mid single digits in local currencies, and tightened its adjusted EBITDA margin range upward to 16.5%–16.8% of sales from the previous 15.5%–16.5% band — a midpoint improvement of 60 basis points.

The company also disclosed CHF 6 million in tariff refunds received in the second half of 2026 under the International Emergency Economic Powers Act, adding an incremental positive to the financial picture. Tecan’s "Rewired" transformation program, targeting portfolio discipline and operational excellence, was confirmed to be progressing on schedule, and the company reiterated its medium-term 2028 targets.

At the segment level, the Life Sciences Business was a key engine of growth, fuelled by strong demand from biopharma customers and a significant increase in liquid handling instrument revenues, while recurring revenues from services, consumables, and reagents continued to expand steadily.

The broader Swiss market had closed the prior session on a constructive note amid easing trade and inflation concerns, while U.S. indices were mixed on the day, making the macro backdrop broadly neutral — underscoring that today’s sharp move was almost entirely company-driven.

Taken together, the combination of above-expectation Q3 sales momentum, a double upgrade to the full-year outlook, and confirmation of the medium-term roadmap gave investors a compelling reason to re-rate the shares, pushing Tecan to a fresh 52-week high of CHF 269.8 during the session.